Nuclear Hypoxia-Inducible Factor 1 Alpha as a Predictor of Recurrence Pattern and Overall Survival in Resected Pancreatic Adenocarcinoma Público

Colbert, Lauren Elizabeth (2014)

Permanent URL: https://etd.library.emory.edu/concern/etds/pg15bf56q?locale=es
Published

Abstract

Purpose:
Nuclear Hypoxia-Inducible Factor 1 Alpha (HIF1a) has been implicated in development of cancer metastases. The goal of this analysis was to evaluate HIF1a expression as a prognostic factor for overall survival (OS), distant recurrence (DR) and local recurrence (LR) following resection for pancreatic adenocarcinoma (PAC).

Methods:
Specimens were collected from 98 patients with PAC who underwent resection without neoadjuvant therapy between January 2000 and December 2011 at one institution. Immunohistochemical (IHC) staining was performed using anti-HIF1a antibody and scored using a previously defined scoring system by an independent pathologist blinded to patient outcomes. Univariate analysis was used to compare HIF1a scores for LR and DR groups and for OS. Multivariate logistic regression was used to determine predictors of LR and DR. A receiver operating characteristic (ROC) curve was conducted for predictive power of HIF1a expression on DR.

Results:
8 (8%) patients demonstrated isolated LR, 26 (26.5%) patients had isolated DR, and 13 patients had both LR and DR. 53 (54%) patients had high HIF1a expression and 45 (46%) patients had low HIF1a expression. High HIF1a expression was significantly associated with DR (p=0.03) and low HIF1a expression was significantly associated with isolated LR (p=.02). In multivariate logistic regression analysis adjusting for nodal status, margin status, tumor grade, perineural invasion, lymphovascular invasion and use of adjuvant therapy, high HIF1a was the only significant predictor of DR (OR=3.10 [95% CI 1.18-8.10]; p=.02). In patients with a recurrence, the AUC of high HIF1a score for DR was 74.8%. A HIF1a score ≥ 2.5 demonstrated a specificity of 100% for DR in these patients.

Conclusions:
High HIF1a expression is a predictor of distant failure versus isolated local failure in patients undergoing resection of pancreatic adenocarcinoma. HIF1a expression may have utility as a clinical decision-making tool to determine candidates for adjuvant local therapy and systemic chemotherapy.

Table of Contents

TABLE OF CONTENTS
INTRODUCTION & BACKGROUND...1
METHODS...3
RESULTS...8
DISCUSSION & CONCLUSIONS...11
REFERENCES...14
TABLES 1-8...20
FIGURES 1-3...26

About this Master's Thesis

Rights statement
  • Permission granted by the author to include this thesis or dissertation in this repository. All rights reserved by the author. Please contact the author for information regarding the reproduction and use of this thesis or dissertation.
School
Department
Degree
Submission
Language
  • English
Research Field
Palabra Clave
Committee Chair / Thesis Advisor
Committee Members
Última modificación

Primary PDF

Supplemental Files